PML Risk Stratification Using Anti-JCV Antibody Index and L-Selectin
Multiple Sclerosis - United States
doi 10.1177/1352458515607651
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 2, 2015
Authors
Publisher
SAGE Publications